|
TSTD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
1.78989999488621E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
7.010000E-01 |
| Stage1-vs-Stage3 |
1.436200E-03 |
| Stage1-vs-Stage4 |
2.384000E-03 |
| Stage2-vs-Stage3 |
1.002780E-01 |
| Stage2-vs-Stage4 |
1.054440E-01 |
| Stage3-vs-Stage4 |
7.374000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.21840315614463E-11 |
| Normal-vs-Asian |
1.251420E-01 |
| Caucasian-vs-AfricanAmerican |
7.822000E-01 |
| Caucasian-vs-Asian |
6.000300E-02 |
| AfricanAmerican-vs-Asian |
7.354300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.72017955435422E-12 |
| Male-vs-Female |
5.578100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.17729997656846E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.50239995391865E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.534600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.486400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.844000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.280360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.290200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.211400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.262200E-03 |
| Normal-vs-Grade 2 |
3.2218672174622E-13 |
| Normal-vs-Grade 3 |
1.6242562850266E-12 |
| Normal-vs-Grade 4 |
1.62481139653892E-12 |
| Grade 1-vs-Grade 2 |
2.854000E-01 |
| Grade 1-vs-Grade 3 |
1.456340E-02 |
| Grade 1-vs-Grade 4 |
1.381720E-02 |
| Grade 2-vs-Grade 3 |
8.014900E-04 |
| Grade 2-vs-Grade 4 |
4.413700E-04 |
| Grade 3-vs-Grade 4 |
2.150600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.69686487083709E-12 |
| Normal-vs-ccB subtype |
1.62503344114384E-12 |
| ccA subtype-vs-ccB subtype |
1.867990E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55111512312578E-16 |
| Normal-vs-N1 |
5.63099999961736E-09 |
| N0-vs-N1 |
1.072800E-01 |
|
|
